In addition, ADAM17 promotes chemotherapy resistance and tumor cell proliferation and survival by shedding EGFR ligands (e.g., Amphiregulin, AREG) (Hugendieck et al., 2023). The gene discussed is EGFR; the disease is neoplasm.